[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2015-2027 Global Opioids Drugs Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region

June 2020 | 120 pages | ID: 223F2012C08FEN
Maia Research

US$ 3,460.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The worldwide market for Opioids Drugs is estimated to grow at a CAGR of roughly X.X% in the next 8 years, and will reach X.X million US$ in 2027, from X.X million US$ in 2020.

The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in Major Regions, such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, by type, application and marketing channel. In addition, the report focuses on the driving factors, restraints, opportunities and PEST analysis of major regions.

Major Companies Covered
Teva pharmaceuticals
Hospira
Sanofi-aventis US LLC
Endo Pharmaceuticals
Purdue Pharma
Orexo Pharmaceuticals
Allergan
Pfizer
AbbVie
Johnson & Johnson

Major Types Covered
Oxycodone (e.g., OxyContin, Percocet)
Hydrocodone (e.g., Vicodin)
Codeine
Morphine (e.g., Kadian, Avinza)
Others

Major Applications Covered
Neuropathic pain treatment
Orthopedic pain treatment
Other pain treatment

Top Countries Data Covered in This Report
United States
Canada
Germany
UK
France
Italy
Spain
Russia
Netherlands
Turkey
Switzerland
Sweden
Poland
Belgium
China
Japan
South Korea
Australia
India
Taiwan
Indonesia
Thailand
Philippines
Malaysia
Brazil
Mexico
Argentina
Columbia
Chile
Saudi Arabia
UAE
Egypt
Nigeria
South Africa

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2027
1 INTRODUCTION

1.1 Objective of the Study
1.2 Definition of the Market
1.3 Market Scope
  1.3.1 Market Segment by Type, Application and Marketing Channel
  1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa)
1.4 Years Considered for the Study (2015-2027)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders

2 KEY FINDINGS OF THE STUDY

3 MARKET DYNAMICS

3.1 Driving Factors for this Market
3.2 Factors Challenging the Market
3.3 Opportunities of the Global Opioids Drugs Market (Regions, Growing/Emerging Downstream Market Analysis)
3.4 Technological and Market Developments in the Opioids Drugs Market
3.5 Industry News by Region
3.6 Regulatory Scenario by Region/Country
3.7 Market Investment Scenario Strategic Recommendations Analysis

4 VALUE CHAIN OF THE OPIOIDS DRUGS MARKET

4.1 Value Chain Status
4.2 Upstream Raw Material Analysis
4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
4.4 Distributors/Traders
4.5 Downstream Major Customer Analysis (by Region)

5 GLOBAL OPIOIDS DRUGS MARKET-SEGMENTATION BY TYPE

5.1 Oxycodone (e.g., OxyContin, Percocet)
5.2 Hydrocodone (e.g., Vicodin)
5.3 Codeine
5.4 Morphine (e.g., Kadian, Avinza)
5.5 Others

6 GLOBAL OPIOIDS DRUGS MARKET-SEGMENTATION BY APPLICATION

6.1 Neuropathic pain treatment
6.2 Orthopedic pain treatment
6.3 Other pain treatment

7 GLOBAL OPIOIDS DRUGS MARKET-SEGMENTATION BY MARKETING CHANNEL

7.1 Traditional Marketing Channel (Offline)
7.2 Online Channel

8 COMPETITIVE INTELLIGENCE – COMPANY PROFILES

8.1 Teva pharmaceuticals
  8.1.1 Teva pharmaceuticals Profile
  8.1.2 Teva pharmaceuticals Sales, Growth Rate and Global Market Share from 2015-2020
  8.1.3 Teva pharmaceuticals Product/Solution Launches and Enhancements Analysis
  8.1.4 Teva pharmaceuticals Business Overview/Recent Development/Acquisitions
8.2 Hospira
  8.2.1 Hospira Profile
  8.2.2 Hospira Sales, Growth Rate and Global Market Share from 2015-2020
  8.2.3 Hospira Product/Solution Launches and Enhancements Analysis
  8.2.4 Hospira Business Overview/Recent Development/Acquisitions
8.3 Sanofi-aventis US LLC
  8.3.1 Sanofi-aventis US LLC Profile
  8.3.2 Sanofi-aventis US LLC Sales, Growth Rate and Global Market Share from 2015-2020
  8.3.3 Sanofi-aventis US LLC Product/Solution Launches and Enhancements Analysis
  8.3.4 Sanofi-aventis US LLC Business Overview/Recent Development/Acquisitions
8.4 Endo Pharmaceuticals
  8.4.1 Endo Pharmaceuticals Profile
  8.4.2 Endo Pharmaceuticals Sales, Growth Rate and Global Market Share from 2015-2020
  8.4.3 Endo Pharmaceuticals Product/Solution Launches and Enhancements Analysis
  8.4.4 Endo Pharmaceuticals Business Overview/Recent Development/Acquisitions
8.5 Purdue Pharma
  8.5.1 Purdue Pharma Profile
  8.5.2 Purdue Pharma Sales, Growth Rate and Global Market Share from 2015-2020
  8.5.3 Purdue Pharma Product/Solution Launches and Enhancements Analysis
  8.5.4 Purdue Pharma Business Overview/Recent Development/Acquisitions
8.6 Orexo Pharmaceuticals
  8.6.1 Orexo Pharmaceuticals Profile
  8.6.2 Orexo Pharmaceuticals Sales, Growth Rate and Global Market Share from 2015-2020
  8.6.3 Orexo Pharmaceuticals Product/Solution Launches and Enhancements Analysis
  8.6.4 Orexo Pharmaceuticals Business Overview/Recent Development/Acquisitions
8.7 Allergan
  8.7.1 Allergan Profile
  8.7.2 Allergan Sales, Growth Rate and Global Market Share from 2015-2020
  8.7.3 Allergan Product/Solution Launches and Enhancements Analysis
  8.7.4 Allergan Business Overview/Recent Development/Acquisitions
8.8 Pfizer
  8.8.1 Pfizer Profile
  8.8.2 Pfizer Sales, Growth Rate and Global Market Share from 2015-2020
  8.8.3 Pfizer Product/Solution Launches and Enhancements Analysis
  8.8.4 Pfizer Business Overview/Recent Development/Acquisitions
8.9 AbbVie
  8.9.1 AbbVie Profile
  8.9.2 AbbVie Sales, Growth Rate and Global Market Share from 2015-2020
  8.9.3 AbbVie Product/Solution Launches and Enhancements Analysis
  8.9.4 AbbVie Business Overview/Recent Development/Acquisitions
8.10 Johnson & Johnson
  8.10.1 Johnson & Johnson Profile
  8.10.2 Johnson & Johnson Sales, Growth Rate and Global Market Share from 2015-2020
  8.10.3 Johnson & Johnson Product/Solution Launches and Enhancements Analysis
  8.10.4 Johnson & Johnson Business Overview/Recent Development/Acquisitions

9 GLOBAL OPIOIDS DRUGS MARKET-SEGMENTATION BY GEOGRAPHY

10 NORTH AMERICA

10.1 North America Opioids Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
10.2 North America Opioids Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
10.3 North America Opioids Drugs Production Analysis from 2015-2020
10.4 North America Opioids Drugs Consumption Analysis from 2015-2020
10.5 North America Opioids Drugs Import and Export from 2015-2020
10.6 North America Opioids Drugs Value, Production and Market Share by Type (2015-2020)
10.7 North America Opioids Drugs Consumption, Value and Market Share by Application (2015-2020)
10.8 North America Opioids Drugs by Country (United States, Canada)
  10.8.1 North America Opioids Drugs Sales by Country (2015-2020)
  10.8.2 North America Opioids Drugs Consumption Value by Country (2015-2020)
10.9 North America Opioids Drugs Market PEST Analysis

11 EUROPE

11.1 Europe Opioids Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
11.2 Europe Opioids Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
11.3 Europe Opioids Drugs Production Analysis from 2015-2020
11.4 Europe Opioids Drugs Consumption Analysis from 2015-2020
11.5 Europe Opioids Drugs Import and Export from 2015-2020
11.6 Europe Opioids Drugs Value, Production and Market Share by Type (2015-2020)
11.7 Europe Opioids Drugs Consumption, Value and Market Share by Application (2015-2020)
11.8 Europe Opioids Drugs by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium)
  11.8.1 Europe Opioids Drugs Sales by Country (2015-2020)
  11.8.2 Europe Opioids Drugs Consumption Value by Country (2015-2020)
11.9 Europe Opioids Drugs Market PEST Analysis

12 ASIA-PACIFIC

12.1 Asia-Pacific Opioids Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
12.2 Asia-Pacific Opioids Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
12.3 Asia-Pacific Opioids Drugs Production Analysis from 2015-2020
12.4 Asia-Pacific Opioids Drugs Consumption Analysis from 2015-2020
12.5 Asia-Pacific Opioids Drugs Import and Export from 2015-2020
12.6 Asia-Pacific Opioids Drugs Value, Production and Market Share by Type (2015-2020)
12.7 Asia-Pacific Opioids Drugs Consumption, Value and Market Share by Application (2015-2020)
12.8 Asia-Pacific Opioids Drugs by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia)
  12.8.1 Asia-Pacific Opioids Drugs Sales by Country (2015-2020)
  12.8.2 Asia-Pacific Opioids Drugs Consumption Value by Country (2015-2020)
12.9 Asia-Pacific Opioids Drugs Market PEST Analysis

13 LATIN AMERICA

13.1 Latin America Opioids Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
13.2 Latin America Opioids Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
13.3 Latin America Opioids Drugs Production Analysis from 2015-2020
13.4 Latin America Opioids Drugs Consumption Analysis from 2015-2020
13.5 Latin America Opioids Drugs Import and Export from 2015-2020
13.6 Latin America Opioids Drugs Value, Production and Market Share by Type (2015-2020)
13.7 Latin America Opioids Drugs Consumption, Value and Market Share by Application (2015-2020)
13.8 Latin America Opioids Drugs by Country (Brazil, Mexico, Argentina, Columbia, Chile)
  13.8.1 Latin America Opioids Drugs Sales by Country (2015-2020)
  13.8.2 Latin America Opioids Drugs Consumption Value by Country (2015-2020)
13.9 Latin America Opioids Drugs Market PEST Analysis

14 MIDDLE EAST & AFRICA

14.1 Middle East & Africa Opioids Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
14.2 Middle East & Africa Opioids Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
14.3 Middle East & Africa Opioids Drugs Production Analysis from 2015-2020
14.4 Middle East & Africa Opioids Drugs Consumption Analysis from 2015-2020
14.5 Middle East & Africa Opioids Drugs Import and Export from 2015-2020
14.6 Middle East & Africa Opioids Drugs Value, Production and Market Share by Type (2015-2020)
14.7 Middle East & Africa Opioids Drugs Consumption, Value and Market Share by Application (2015-2020)
14.8 Middle East & Africa Opioids Drugs by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)
  14.8.1 Middle East & Africa Opioids Drugs Sales by Country (2015-2020)
  14.8.2 Middle East & Africa Opioids Drugs Consumption Value by Country (2015-2020)
14.9 Middle East & Africa Opioids Drugs Market PEST Analysis

15 FUTURE FORECAST OF THE GLOBAL OPIOIDS DRUGS MARKET FROM 2020-2027

15.1 Future Forecast of the Global Opioids Drugs Market from 2020-2027 Segment by Region
15.2 Global Opioids Drugs Production and Growth Rate Forecast by Type (2020-2027)
15.3 Global Opioids Drugs Consumption and Growth Rate Forecast by Application (2020-2027)

16 APPENDIX

16.1 Methodology
16.2 Research Data Source
LIST OF TABLES AND FIGURES

Global Opioids Drugs Market Value ($) and Growth Rate of Opioids Drugs from 2015-2027
Global Opioids Drugs Production and Growth Rate Segment by Product Type from 2015-2027
Global Opioids Drugs Consumption and Growth Rate Segment by Application from 2015-2027
Figure Opioids Drugs Picture
Table Product Specifications of Opioids Drugs
Table Driving Factors for this Market
Table Industry News of Opioids Drugs Market
Figure Value Chain Status of Opioids Drugs
Table Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
Table Distributors/Traders
Table Downstream Major Customer Analysis (by Region, by Preference)
Table Global Opioids Drugs Production and Growth Rate Segment by Product Type from 2015-2020
Table Global Opioids Drugs Value ($) and Growth Rate Segment by Product Type from 2015-2020
Figure Oxycodone (e.g., OxyContin, Percocet) of Opioids Drugs
Figure Hydrocodone (e.g., Vicodin) of Opioids Drugs
Figure Codeine of Opioids Drugs
Figure Morphine (e.g., Kadian, Avinza) of Opioids Drugs
Figure Others of Opioids Drugs
Table Global Opioids Drugs Consumption and Growth Rate Segment by Application from 2015-2020
Table Global Opioids Drugs Value ($) and Growth Rate Segment by Application from 2015-2020
Figure Neuropathic pain treatment of Opioids Drugs
Figure Orthopedic pain treatment of Opioids Drugs
Figure Other pain treatment of Opioids Drugs
Table Global Opioids Drugs Consumption and Growth Rate Segment by Marketing Channel from 2015-2020
Table Global Opioids Drugs Value ($) and Growth Rate Segment by Marketing Channel from 2015-2020
Figure Traditional Marketing Channel (Offline) of Opioids Drugs
Figure Online Channel of Opioids Drugs
Table Teva pharmaceuticals Profile (Company Name, Plants Distribution, Sales Region)
Figure Teva pharmaceuticals Sales and Growth Rate from 2015-2020
Figure Teva pharmaceuticals Revenue ($) and Global Market Share from 2015-2020
Table Teva pharmaceuticals Opioids Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table Hospira Profile (Company Name, Plants Distribution, Sales Region)
Figure Hospira Sales and Growth Rate from 2015-2020
Figure Hospira Revenue ($) and Global Market Share from 2015-2020
Table Hospira Opioids Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table Sanofi-aventis US LLC Profile (Company Name, Plants Distribution, Sales Region)
Figure Sanofi-aventis US LLC Sales and Growth Rate from 2015-2020
Figure Sanofi-aventis US LLC Revenue ($) and Global Market Share from 2015-2020
Table Sanofi-aventis US LLC Opioids Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table Endo Pharmaceuticals Profile (Company Name, Plants Distribution, Sales Region)
Figure Endo Pharmaceuticals Sales and Growth Rate from 2015-2020
Figure Endo Pharmaceuticals Revenue ($) and Global Market Share from 2015-2020
Table Endo Pharmaceuticals Opioids Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table Purdue Pharma Profile (Company Name, Plants Distribution, Sales Region)
Figure Purdue Pharma Sales and Growth Rate from 2015-2020
Figure Purdue Pharma Revenue ($) and Global Market Share from 2015-2020
Table Purdue Pharma Opioids Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table Orexo Pharmaceuticals Profile (Company Name, Plants Distribution, Sales Region)
Figure Orexo Pharmaceuticals Sales and Growth Rate from 2015-2020
Figure Orexo Pharmaceuticals Revenue ($) and Global Market Share from 2015-2020
Table Orexo Pharmaceuticals Opioids Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table Allergan Profile (Company Name, Plants Distribution, Sales Region)
Figure Allergan Sales and Growth Rate from 2015-2020
Figure Allergan Revenue ($) and Global Market Share from 2015-2020
Table Allergan Opioids Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table Pfizer Profile (Company Name, Plants Distribution, Sales Region)
Figure Pfizer Sales and Growth Rate from 2015-2020
Figure Pfizer Revenue ($) and Global Market Share from 2015-2020
Table Pfizer Opioids Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table AbbVie Profile (Company Name, Plants Distribution, Sales Region)
Figure AbbVie Sales and Growth Rate from 2015-2020
Figure AbbVie Revenue ($) and Global Market Share from 2015-2020
Table AbbVie Opioids Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table Johnson & Johnson Profile (Company Name, Plants Distribution, Sales Region)
Figure Johnson & Johnson Sales and Growth Rate from 2015-2020
Figure Johnson & Johnson Revenue ($) and Global Market Share from 2015-2020
Table Johnson & Johnson Opioids Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table Global Opioids Drugs Production Value ($) by Region from 2015-2020
Table Global Opioids Drugs Production Value Share by Region from 2015-2020
Table Global Opioids Drugs Production by Region from 2015-2020
Table Global Opioids Drugs Consumption Value ($) by Region from 2015-2020
Table Global Opioids Drugs Consumption by Region from 2015-2020
Table North America Opioids Drugs Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table North America Opioids Drugs Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table North America Opioids Drugs Import and Export from 2015-2020
Table North America Opioids Drugs Value ($) by Type (2015-2020)
Table North America Opioids Drugs Production by Type (2015-2020)
Table North America Opioids Drugs Consumption by Application (2015-2020)
Table North America Opioids Drugs Consumption by Country (2015-2020)
Table North America Opioids Drugs Consumption Value ($) by Country (2015-2020)
Figure North America Opioids Drugs Market PEST Analysis
Table Europe Opioids Drugs Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Europe Opioids Drugs Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Europe Opioids Drugs Import and Export from 2015-2020
Table Europe Opioids Drugs Value ($) by Type (2015-2020)
Table Europe Opioids Drugs Production by Type (2015-2020)
Table Europe Opioids Drugs Consumption by Application (2015-2020)
Table Europe Opioids Drugs Consumption by Country (2015-2020)
Table Europe Opioids Drugs Consumption Value ($) by Country (2015-2020)
Figure Europe Opioids Drugs Market PEST Analysis
Table Asia-Pacific Opioids Drugs Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Asia-Pacific Opioids Drugs Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Asia-Pacific Opioids Drugs Import and Export from 2015-2020
Table Asia-Pacific Opioids Drugs Value ($) by Type (2015-2020)
Table Asia-Pacific Opioids Drugs Production by Type (2015-2020)
Table Asia-Pacific Opioids Drugs Consumption by Application (2015-2020)
Table Asia-Pacific Opioids Drugs Consumption by Country (2015-2020)
Table Asia-Pacific Opioids Drugs Consumption Value ($) by Country (2015-2020)
Figure Asia-Pacific Opioids Drugs Market PEST Analysis
Table Latin America Opioids Drugs Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Latin America Opioids Drugs Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Latin America Opioids Drugs Import and Export from 2015-2020
Table Latin America Opioids Drugs Value ($) by Type (2015-2020)
Table Latin America Opioids Drugs Production by Type (2015-2020)
Table Latin America Opioids Drugs Consumption by Application (2015-2020)
Table Latin America Opioids Drugs Consumption by Country (2015-2020)
Table Latin America Opioids Drugs Consumption Value ($) by Country (2015-2020)
Figure Latin America Opioids Drugs Market PEST Analysis
Table Middle East & Africa Opioids Drugs Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Middle East & Africa Opioids Drugs Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Middle East & Africa Opioids Drugs Import and Export from 2015-2020
Table Middle East & Africa Opioids Drugs Value ($) by Type (2015-2020)
Table Middle East & Africa Opioids Drugs Production by Type (2015-2020)
Table Middle East & Africa Opioids Drugs Consumption by Application (2015-2020)
Table Middle East & Africa Opioids Drugs Consumption by Country (2015-2020)
Table Middle East & Africa Opioids Drugs Consumption Value ($) by Country (2015-2020)
Figure Middle East & Africa Opioids Drugs Market PEST Analysis
Table Global Opioids Drugs Value ($) and Growth Rate Forecast by Region (2020-2027)
Table Global Opioids Drugs Production and Growth Rate Forecast by Region (2020-2027)
Table Global Opioids Drugs Consumption and Growth Rate Forecast by Region (2020-2027)
Table Global Opioids Drugs Production and Growth Rate Forecast by Type (2020-2027)
Table Global Opioids Drugs Consumption and Growth Rate Forecast by Application (2020-2027)


More Publications